Clinical Trial: A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Alzheimer's Disease
Study Type: INTERVENTIONAL
Official Title: A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD)
Brief Summary:
This is a randomized, double-blind, placebo-controlled first-in-human, Phase 1, safety, tolerability, pharmacokinetic (PK) and preliminary exploratory activity study of escalating multiple intravenous (IV) doses of IBC-Ab002 in persons with early Alzheimer's disease.The study will have both Single- and Multiple-Ascending Dose components.
Read more